FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions relates to biotechnology. An oral pharmaceutical composition for oral administration of protein into an individual contains a protein of molecular weight to 100000 Da, a first protease inhibitor and a second protease inhibitor. The above first protease inhibitor represents aprotining, while the second protease inhibitor is specified in a group consisting of soya bean trypsin inhibitor (SBTI) and Bowman-Birk protease inhibitor (BBPI).
EFFECT: using the given composition provides higher bioavailability and absorption of the orally administered protein.
19 cl, 9 dwg, 5 ex
